4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-000624
Chief Scientific Officer gave up 41,851 shares (to pay taxes)
- Chief Scientific Officer acquired 91,130 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2024-12-31 | Option exercise | +73,750 | 245,533 | D: show line 1 in the form | ||
| Monahan Joseph Chief Scientific Officer | 2024-12-31 | Shares withheld for taxes | −32,937 | 212,596 | D: show line 2 in the form | ||
| Monahan Joseph Chief Scientific Officer | 2025-01-02 | Option exercise | +17,380 | 229,976 | D: show line 3 in the form | ||
| Monahan Joseph Chief Scientific Officer | 2025-01-02 | Shares withheld for taxes | −8,914 | 221,062 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2024-12-31 | Option exercise · Restricted Stock Units | −73,750 | 73,750 | D: show line 5 in the form | |||||
| Monahan Joseph Chief Scientific Officer | 2025-01-02 | Grant or award · Restricted Stock Units | +52,667 | 52,667 | D: show line 6 in the form | |||||
| Monahan Joseph Chief Scientific Officer | 2025-01-02 | Option exercise · Restricted Stock Units | −17,380 | 35,287 | D: show line 7 in the form |
Loading xslF345X05/form4-01032025_060109.xml…